|Description||European venture capital firms|
BioMedInvest AG is a healthcare-dedicated venture capital fund based in Switzerland, providing private equity financing to early- to mid-stage companies in Switzerland and neighbouring regions (Alpine Rim). BioMedInvest currently invests out of Fund I, which has a size of CHF 100 million and was closed in 2003.
|Delenex Therapeutics||5/11||Series A||$19.3M||6|
|Delenex Therapeutics||11/10||Series A||$14M||4|
|Affimed Therapeutics||4/10||Series C||€20M||3|